XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2021   282,526,719        
Beginning balance at Dec. 31, 2021 $ 409,222 $ 2,825 $ 937,805 $ (91,774) $ (439,634)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 149,058       149,058  
Other comprehensive loss (10,155)     (10,155)    
Dividends declared (25,623)       (25,623)  
Shares issued in connection with deferred compensation plan, net (in shares)   3,523,386        
Shares issued in connection with deferred compensation plan, net (24,246) $ 35 (27)   (24,254)  
Deferred compensation plan elective participant deferrals 4,694   4,694      
Shares issued in connection with executive bonus plan, net (in shares)   284,992        
Shares issued in connection with executive bonus plan, net 11,113 $ 3 16,307   (5,197)  
Shares issued in connection with employee stock purchase plan, net (in shares)   307,406        
Shares issued in connection with employee stock purchase plan, net 10,062 $ 3 10,332   (273)  
Stock option exercises, net (in shares)   2,272,603        
Stock option exercises, net (1,604) $ 23 6,832   (8,459)  
Acquisition option exercises, net (in shares)   185,178        
Acquisition option exercises, net 0 $ 2 (2)      
Shares issued for stock grants, net (in shares)   13,632        
Shares issued for stock grants, net 450   450      
Stock-based compensation expense 28,687   28,687      
Shares related to restricted stock, net (in shares)   199,975        
Shares related to restricted stock, net (3,209) $ 2 (3)   (3,208)  
Repurchases of Class B common stock under approved program (in shares)   (896,126)        
Repurchases of Class B Common Stock under approved program (28,250) $ (9)     (28,241)  
Ending balance (in shares) at Sep. 30, 2022   288,417,765        
Ending balance at Sep. 30, 2022 520,199 $ 2,884 1,005,075 (101,929) (385,831)  
Beginning balance (in shares) at Jun. 30, 2022   288,154,159        
Beginning balance at Jun. 30, 2022 496,993 $ 2,882 981,203 (89,131) (397,961)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 36,997       36,997  
Other comprehensive loss (12,798)     (12,798)    
Dividends declared (8,592)       (8,592)  
Shares issued in connection with deferred compensation plan, net (in shares)   97,591        
Shares issued in connection with deferred compensation plan, net 0 $ 1 (1)      
Deferred compensation plan elective participant deferrals 1,586   1,586      
Shares issued in connection with executive bonus plan, net (in shares)   125,195        
Shares issued in connection with executive bonus plan, net 4,417 $ 1 4,416      
Shares issued in connection with employee stock purchase plan, net (in shares)   197,657        
Shares issued in connection with employee stock purchase plan, net 5,572 $ 2 5,722   (152)  
Stock option exercises, net (in shares)   218,018        
Stock option exercises, net 935 $ 2 992   (59)  
Stock-based compensation expense 11,158   11,158      
Shares related to restricted stock, net (in shares)   58,270        
Shares related to restricted stock, net (1,061)   (1)   (1,060)  
Repurchases of Class B common stock under approved program (in shares)   (433,125)        
Repurchases of Class B Common Stock under approved program (15,008) $ (4)     (15,004)  
Ending balance (in shares) at Sep. 30, 2022   288,417,765        
Ending balance at Sep. 30, 2022 520,199 $ 2,884 1,005,075 (101,929) (385,831)  
Beginning balance (in shares) at Dec. 31, 2022   289,014,487        
Beginning balance at Dec. 31, 2022 573,454 $ 2,890 1,030,466 (89,740) (370,866) $ 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 147,202       147,202  
Other comprehensive loss (5,388)     (5,388)    
Dividends declared (43,992)       (43,992)  
Shares issued in connection with deferred compensation plan, net (in shares)   2,845,448        
Shares issued in connection with deferred compensation plan, net (38,456) $ 28 (28)   (38,456)  
Deferred compensation plan elective participant deferrals 1,712   1,712      
Shares issued in connection with executive bonus plan, net (in shares)   171,510        
Shares issued in connection with executive bonus plan, net 7,301 $ 2 13,055   (5,756)  
Shares issued in connection with employee stock purchase plan, net (in shares)   315,840        
Shares issued in connection with employee stock purchase plan, net 9,143 $ 3 9,985   (845)  
Stock option exercises, net (in shares)   2,422,082        
Stock option exercises, net 4,182 $ 24 10,566   (6,408)  
Shares issued for stock grants, net (in shares)   12,639        
Shares issued for stock grants, net 600   600      
Stock-based compensation expense 42,465   42,465      
Shares related to restricted stock, net (in shares)   462,200        
Shares related to restricted stock, net (6,062) $ 5 (5)   (6,062)  
Ending balance (in shares) at Sep. 30, 2023   295,244,206        
Ending balance at Sep. 30, 2023 692,161 $ 2,952 1,108,816 (95,128) (325,183) 704
Beginning balance (in shares) at Jun. 30, 2023   294,712,983        
Beginning balance at Jun. 30, 2023 643,772 $ 2,947 1,085,066 (87,828) (357,117) 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 53,027       53,027  
Other comprehensive loss (7,300)     (7,300)    
Dividends declared (14,768)       (14,768)  
Shares issued in connection with deferred compensation plan, net (in shares)   63,267        
Shares issued in connection with deferred compensation plan, net (2,127)       (2,127)  
Deferred compensation plan elective participant deferrals 61   61      
Shares issued in connection with executive bonus plan, net (in shares)   34,313        
Shares issued in connection with executive bonus plan, net 1,821   3,251   (1,430)  
Shares issued in connection with employee stock purchase plan, net (in shares)   162,459        
Shares issued in connection with employee stock purchase plan, net 4,808 $ 2 5,429   (623)  
Stock option exercises, net (in shares)   185,255        
Stock option exercises, net 471 $ 2 888   (419)  
Stock-based compensation expense 14,122   14,122      
Shares related to restricted stock, net (in shares)   85,929        
Shares related to restricted stock, net (1,726) $ 1 (1)   (1,726)  
Ending balance (in shares) at Sep. 30, 2023   295,244,206        
Ending balance at Sep. 30, 2023 $ 692,161 $ 2,952 $ 1,108,816 $ (95,128) $ (325,183) $ 704